Hamilelikte acrylamide/ sodium acryloyldimethyltaurate copolymer kullanmaktan kaçınmalı mıyım? | VeriMom
Harmonised CLP and ECHA list acrylamide (CAS 79-06-1) as Carc. 1B (H350), Muta.1B (H340) and Repr.2 (H361f), which justifies a suspected reproductive/carcinogenic hazard for the acrylamide monomer. Regulatory and safety reviews (CIR) treat acrylamide‑containing polymers as acceptable only if residual monomer is controlled (e.g., ≤0.1 mg/kg for leave‑on in EU), so mechanism evidence and animal reproductive findings support m=2 and a measurable but low dermal exposure for cosmetics (e=1). (Sources: ECHA harmonised classification; CIR safety assessments; EU Annex III restriction).
ECHA regulatory hazard statements
- •H350
- •H361F
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- acrylamide/ sodium acryloyldimethyltaurate copolymer hamilelikte güvenli mi?
- Harmonised CLP and ECHA list acrylamide (CAS 79-06-1) as Carc. 1B (H350), Muta.1B (H340) and Repr.2 (H361f), which justifies a suspected reproductive/carcinogenic hazard for the acrylamide monomer. Regulatory and safety reviews (CIR) treat acrylamide‑containing polymers as acceptable only if residual monomer is controlled (e.g., ≤0.1 mg/kg for leave‑on in EU), so mechanism evidence and animal reproductive findings support m=2 and a measurable but low dermal exposure for cosmetics (e=1). (Sources: ECHA harmonised classification; CIR safety assessments; EU Annex III restriction).
- acrylamide/ sodium acryloyldimethyltaurate copolymer emzirirken güvenli mi?
- Same basis as pregnancy: the hazard derives from acrylamide monomer (harmonised classification and animal data). For topical cosmetic use of the polymer, exposure to acrylamide is low when residual monomer is controlled to regulatory limits, but measurable exposures have been reported in products; therefore a conservative suspected hazard (h=2), demonstrated mechanism (m=2) and low but measurable exposure (e=1) are retained.
- acrylamide/ sodium acryloyldimethyltaurate copolymer bebek cildi için güvenli mi?
- Hazard and mechanism remain tied to acrylamide monomer. Because infant skin has higher permeability and surface‑area‑to‑weight, exposure score is increased by +1 relative to adult topical use (adult e=1 → infant e=2), while h and m are unchanged absent infant‑specific toxicology showing different effects. Regulatory residual limits still apply; if residuals are not controlled, infant exposure concern increases.
- VeriMom acrylamide/ sodium acryloyldimethyltaurate copolymer nasıl puanlıyor?
- VeriMom acrylamide/ sodium acryloyldimethyltaurate copolymer'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.
- Hamilelikte acrylamide/ sodium acryloyldimethyltaurate copolymer yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.